Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial.
Saved in:
| Title: | Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial. |
|---|---|
| Authors: | Pu T; Digestive Oncology, KU Leuven, Belgium., Peddle AM; Digestive Oncology, KU Leuven, Belgium., Wirapati P; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Tsantoulis P; Geneva University Hospitals, Geneva, Switzerland., Wu Q; Digestive Oncology, KU Leuven, Belgium., Hong Y; Digestive Oncology, KU Leuven, Belgium., Samuel L; Oncology Department, School of Medicine, Medical Sciences and Nutrition, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, UK., Desai J; Peter MacCallum Cancer Centre, Melbourne, Australia., Riener M; Docrates Syöpäsairaala, Helsinki, Finland., Saridaki Z; First Oncology Department, Metropolitan Hospital, Piraeus, Greece.; Asklepios, Oncology Department, Heraklion, Greece., Cunningham D; The Royal Marsden Hospital, London, UK., Tejpar S; Digestive Oncology, KU Leuven, Belgium. sabine.tejpar@uzleuven.be. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2026 Jan 13; Vol. 10 (1), pp. 50. Date of Electronic Publication: 2026 Jan 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41530374 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pu+T%22">Pu T</searchLink>; Digestive Oncology, KU Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Peddle+AM%22">Peddle AM</searchLink>; Digestive Oncology, KU Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Wirapati+P%22">Wirapati P</searchLink>; Swiss Institute of Bioinformatics, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tsantoulis+P%22">Tsantoulis P</searchLink>; Geneva University Hospitals, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wu+Q%22">Wu Q</searchLink>; Digestive Oncology, KU Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Hong+Y%22">Hong Y</searchLink>; Digestive Oncology, KU Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Samuel+L%22">Samuel L</searchLink>; Oncology Department, School of Medicine, Medical Sciences and Nutrition, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, UK.<br /><searchLink fieldCode="AU" term="%22Desai+J%22">Desai J</searchLink>; Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Riener+M%22">Riener M</searchLink>; Docrates Syöpäsairaala, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Saridaki+Z%22">Saridaki Z</searchLink>; First Oncology Department, Metropolitan Hospital, Piraeus, Greece.; Asklepios, Oncology Department, Heraklion, Greece.<br /><searchLink fieldCode="AU" term="%22Cunningham+D%22">Cunningham D</searchLink>; The Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Tejpar+S%22">Tejpar S</searchLink>; Digestive Oncology, KU Leuven, Belgium. sabine.tejpar@uzleuven.be. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2026 Jan 13; Vol. 10 (1), pp. 50. <i>Date of Electronic Publication: </i>2026 Jan 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41530374 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41698-025-01253-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 50 Titles: – TitleFull: Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pu T – PersonEntity: Name: NameFull: Peddle AM – PersonEntity: Name: NameFull: Wirapati P – PersonEntity: Name: NameFull: Tsantoulis P – PersonEntity: Name: NameFull: Wu Q – PersonEntity: Name: NameFull: Hong Y – PersonEntity: Name: NameFull: Samuel L – PersonEntity: Name: NameFull: Desai J – PersonEntity: Name: NameFull: Riener M – PersonEntity: Name: NameFull: Saridaki Z – PersonEntity: Name: NameFull: Cunningham D – PersonEntity: Name: NameFull: Tejpar S IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 01 Text: 2026 Jan 13 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2397-768X Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: NPJ precision oncology Type: main |
| ResultId | 1 |